Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I understand from IR that the company is about to list on the OTC in the coming 14 days.
JB
Fortunately no. I bailed during the late Dec 2017 / Jan 2018 spike.
Good luck with this one.
JB
I agree with you and there’s not even a comparison to the much smaller Canadian market where the cannabis players are much more richly valued than stateside.
JB
The strength in this name has been nothing short of impressive.
Congrats to those that have held on thus far. We should be getting news soon regarding an update on the progress of the clinical trial. I believe that will be the next catalyst to take this to the next level.
JB
Long wait over... LDS Starts Operations
https://www.prnewswire.com/news-releases/lifestyle-delivery-systems-facility-receives-tested-material-from-licensed-northern-california-cultivators-and-officially-begins-operations-300539600.html
Lifestyle Delivery Systems' Facility Receives Tested Material from Licensed Northern California Cultivators and Officially Begins Operations
VANCOUVER, British Columbia, Oct. 19, 2017 /PRNewswire/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF) and (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that on October 16, 2017, LDS Scientific took receipt of raw fresh frozen whole plant material for the purpose of extraction and conversion into medicinal cannabis products. The material was tested by an independent third party laboratory in Northern California prior to it being acquired, showing no trace amounts of pesticides, fungicides, mold or infestation. The CSPA Group's extraction team from LDS Scientific has completed the laboratory training of its technicians and lab assistants on October 18, 2017, in preparation for the commencement of operations on October 19, 2017. The City of Adelanto, LDS Scientific and Lifestyle Delivery Systems will be in attendance for the ribbon cutting ceremony at the facility today. In attendance will be Jerry & Debbie Davis of CSPA Group Inc., Brad Eckenweiler, CEO of LDS, the Mayor of Adelanto Richard Kerr, Crystal Elrod of LDS Scientific and team, Gabriel Elliot the City Manager, Jessie Flores Head of Business Development for the City of Adelanto, Mayor Pro Tem Jermaine Wright Sr. and members of the city council and city staff.
Brad Eckenweiler, CEO of LDS, stated, "To say that we are excited about the official commencement of operations here in Adelanto would be a gross understatement. Everyone involved in this project has worked tirelessly, given amazing effort and countless hours of overtime and weekends to bring this project to its ultimate conclusion, a state-of-the-art facility. I have said this before and will continue to remind everyone watching this project develop that if not for all the efforts put forth by the City of Adelanto, its Planning Commission and staff, the City Council, Gabriel Elliot, Jessie Flores and the Mayor of Adelanto Richard Kerr this project would not have been possible." The LDS Scientific's team anticipates commencement of finished product production next week.
JB
Long wait over... LDS Starts Operations
https://www.prnewswire.com/news-releases/lifestyle-delivery-systems-facility-receives-tested-material-from-licensed-northern-california-cultivators-and-officially-begins-operations-300539600.html
Lifestyle Delivery Systems' Facility Receives Tested Material from Licensed Northern California Cultivators and Officially Begins Operations
VANCOUVER, British Columbia, Oct. 19, 2017 /PRNewswire/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF) and (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that on October 16, 2017, LDS Scientific took receipt of raw fresh frozen whole plant material for the purpose of extraction and conversion into medicinal cannabis products. The material was tested by an independent third party laboratory in Northern California prior to it being acquired, showing no trace amounts of pesticides, fungicides, mold or infestation. The CSPA Group's extraction team from LDS Scientific has completed the laboratory training of its technicians and lab assistants on October 18, 2017, in preparation for the commencement of operations on October 19, 2017. The City of Adelanto, LDS Scientific and Lifestyle Delivery Systems will be in attendance for the ribbon cutting ceremony at the facility today. In attendance will be Jerry & Debbie Davis of CSPA Group Inc., Brad Eckenweiler, CEO of LDS, the Mayor of Adelanto Richard Kerr, Crystal Elrod of LDS Scientific and team, Gabriel Elliot the City Manager, Jessie Flores Head of Business Development for the City of Adelanto, Mayor Pro Tem Jermaine Wright Sr. and members of the city council and city staff.
Brad Eckenweiler, CEO of LDS, stated, "To say that we are excited about the official commencement of operations here in Adelanto would be a gross understatement. Everyone involved in this project has worked tirelessly, given amazing effort and countless hours of overtime and weekends to bring this project to its ultimate conclusion, a state-of-the-art facility. I have said this before and will continue to remind everyone watching this project develop that if not for all the efforts put forth by the City of Adelanto, its Planning Commission and staff, the City Council, Gabriel Elliot, Jessie Flores and the Mayor of Adelanto Richard Kerr this project would not have been possible." The LDS Scientific's team anticipates commencement of finished product production next week.
JB
You're welcome AMG!
And that's to your private message to me this today. I honestly could care less what you think. I sold the stock not 5 minutes after I ended that July 28 call. Although my information may be from an outdated conversation, the underlying tone/message, as it relates to the core of the company and its board, is timeless.
There was more to the conversation but I wanted to leave it factual and leave opinion out.
So since the daggers are out, let me make a prediction and I hope to be wrong for the sake of all longs in this name that are here because they believe in the future potential of a breath diagnostic device.
I would bet that 6 months from now, Breathtec will pivot strategically, drop further work on the breath analysis device, and acquire some other company in a completely different sector and sell a new vision. But this will probably happen as part of a new PP at a deeply discounted price where friends and family will be allowed to participate. This is not investment advice. I'm now just opining on what will happen based on my, as AMG said, "outdated BS post @ Btec". So once again, YOU ARE WELCOME.
You can consider this to be my last post to this board and on this subject.
JB
PS. AMG, feel free to "return the favor on one of [my] coveted boards someday in the future". I welcome it any day. Posting varying views is what these boards are all about, after all.
Sorry guys...
Didn't mean to ruffle feathers. I am sure everything is fine and I'm sure everything will work out. I just wanted to post factual information in response to a direct question and held back on personal opinion. We are all big boys and girls, right?
I don't get why anyone bothers looking to these boards to get insight. Call management - it's not that hard. Call and say you own shares and you want to know what the F is going on. Here is a place you can start:
Kal Malhi (he's on the board, he should know what is going on, right?)
Mobile: 604-805-4602
Office: 604-646-1553
Michael Sadhra, CFO
Office: 604-218-6281
For starters, ask why they have not updated their web sites to take Guy LaTorre off as the Chief Executive Officer.
JB
Ok, you asked, here you go...
Below are some details which are from a July 28, 2017 conversation with management. For full disclosure, I have no position in BTH at this time.
- There are issues with the device - high voltage generates high current and fries the low voltage side, have been trying but can't seem to fix it
- Going slower than hoped
- 4 months behind schedule
- Board tired of waiting
- Board wants to know what we are doing going forward
- No alignment for the last 6 weeks leading up to this conversation
- CEO interested in continuing with current business plan
- Board not aligned with current business plan and interested in doing a change in strategic direction
That is all I was told.
JB
I have intel...
but have no way to get it to you as I cannot Private Message.
JB
LDS Production and Sales in California Starting this Month
California recreational cannabis sales start in under 3 months
http://www.cannabisfn.com/lds-aims-start-california-production-october/
JB
LDS Production and Sales in California Starting this Month
California recreational cannabis sales start in under 3 months
http://www.cannabisfn.com/lds-aims-start-california-production-october/
JB
Nice pop last week. Congrats to all longs.
JB
I have what is probably a dumb question.
Does everyone holding this stock assume the company is still on track to develop a breath diagnostic device?
I'd assumed with the multi-months of delays and now the termination of the CEO, that this quest of nut turned out to bee too tough to crack. I have no inside knowledge of this to be true but it's my working assumption.
So if my conjecture above is true, why is anyone still holding the sister company that is trying to use precisely the same technology to do something similar to BTH? I mean there is a lot of air between where it's currently trading and zero.
Just saying.
JB
Huh... didn't know. Thanks AMG!
What time zone is that?
JB
Production in September 2017!
The next 30 days will finally see a hockey stick ramp-up curve in production and sales. The opportunity to buy LDS/LDSYF at current discounted prices is almost behind us. I would suggest you act sooner rather than later.
JB
Stay tuned, September will see news flow and resumption of activity to propel the story/technology forward.
JB
Which one is it? I assume it is based in California?
I'm with you on the "irrational exuberance" that is about to take place over the next 4 months. Very limited ways to play this through investing in a public company in the US. Curious what you hold.
JB
Tick Tock Tick Tock
Just waiting for Aug 25.
JB
You were right. Congrats.
JB
An update to the Human Clinical Trial Timeline was posted a few days ago.
This is an update to the study registered by the https://clinicaltrials.gov web site what was initially posted in this post.
The updated information is accessible here:
https://clinicaltrials.gov/ct2/show/NCT03058705
The updated dates indicate that study is set to commence on October 1, 2017. I'm not certain whether this update was triggered by any developments on the IRB approval front (i.e. an imminent approval) or an update in the normal course as the dates were stale.
Management has indicated the IRB should be approved this month so hopefully it is the former, not the latter.
JB
Expecting Completion of Facility & COO in July w/ Start of Production in August
Good things coming here soon. Expect following developments:
- Final building inspection - July
- Receipt of Certificate of Occupancy (COO) - July
- Receipt of Business License - July
- Calibration of equipment in anticipation of production startup - July
- Start of operations & revenue generation - August
The window of opportunity to buy LDS/LDSYF at these levels is narrowing.
JB
Expecting Completion of Facility & COO in July w/ Start of Production in August
Good things coming here soon. Expect following developments:
- Final building inspection - July
- Receipt of Certificate of Occupancy - July
- Receipt of Business License - July
- Calibration of equipment in anticipation of production startup - July
- Start of operations & revenue generation - August
The window of opportunity to buy LDS/LDSYF at these levels is narrowing.
JB
This is inline with the guidance management has provided me over the last year. I'm glad to see that they've put this in print in black and white.
JB
Good to see this corporate update...
http://imaginmedical.com/wp-content/uploads/2016/02/Press-Release-Mid-Year-Update-Final-6-28-17.pdf
Continuing to chase the elusive IRB approval, but it really appears that management has an inside track on it being approved in early Q3 (i.e. July or basically next month). Continuing to monitor this promising story develop.
JB
Couldn't agree more. Development of working mouthpiece and Zika biomarker identification are key items to track progress on (monthly reports for now).
Also keep an eye on potential licensing deals but I suspect this may happen only once company can show proof of concept on FAIMS.
JB
News Out: Lifestyle Delivery Systems Inc. Purchases Ten Acres in Adelanto, California for the Development of a Contract Cultivation Project
https://lifestyledeliverysystem.com/lifestyle-delivery-systems-inc-purchases-ten-acres-adelanto-california-development-contract-cultivation-project/
JB
News Out: Lifestyle Delivery Systems Inc. Purchases Ten Acres in Adelanto, California for the Development of a Contract Cultivation Project
https://lifestyledeliverysystem.com/lifestyle-delivery-systems-inc-purchases-ten-acres-adelanto-california-development-contract-cultivation-project/
JB
Wealth Research Group published the following report on LDS / LDSYF on June 18, 2017:
http://www.wealthresearchgroup.com/download/3101/
JB
Wealth Research Group published the following report on LDS on June 18, 2017:
http://www.wealthresearchgroup.com/download/3101/
JB
Thanks for sharing your opinion on a stock you no longer own or have any financial interest in.
I look forward to seeing your future views on future developments.
JB
Correct
That is what I believe is the path forward at this juncture.
The potential end-use applications of this technology are virtually limitless. You can slice up the licensing nine ways to Sunday.
You need to, of course, structure said licensing in a way where profit sharing benefits both licensor and BTH if the technology moves to commercial use while in the hands of the licensor.
Of course controlling the license becomes too valuable at some point for the licensor not to possess. So the inevitable acquisition transpires.
JB
Article of interest...
Those following this company may be interested in the last paragraph in the following California related article which states:
www.latimes.com/politics/la-pol-ca-marijuana-enforcement-bill-20170601-story.html
Lifestyle Delivery Systems Announces Completion of Brokered and Non-Brokered Private Placement Financings
http://www.stockhouse.com/news/press-releases/2017/05/31/lifestyle-delivery-systems-announces-completion-of-brokered-and-non-brokered
JB
Lifestyle Delivery Systems Announces Completion of Brokered and Non-Brokered Private Placement Financings
http://www.stockhouse.com/news/press-releases/2017/05/31/lifestyle-delivery-systems-announces-completion-of-brokered-and-non-brokered
JB
Financial Austerity
They are waiting for the IRB approval and then things will get rolling again. Stay tuned...
JB
It is no longer a question of if FAIMS works. Current prototype able to measure at level of PPM - Parts Per Million. Which is all you need for disease detection.
The challenge now is to pick an area of interest and dedicate resources in applying FAIMS to address that area. Given limited resources the company can't do everything at once. It needs to find a niche. It can contemplate licensing technology to others for alternative applications.
JB
Breakout from wedge to the upside has started. Ok so you missed buying in the low US$0.40's earlier this week? It is not too late to get in... here are near term catalysts:
Near term catalysts:
- $12M financing closing next week
- Facility inspection late-May
- Certificate of Occupancy (COO) issued early June
- Production starting immediately following COO
- Conservative revenue estimate at $20M for H2/2017
If you don't heed this advice, you will regret not having purchased LDSYF within 3 months.
JB
Breakout from wedge to the upside has started. Ok so you missed buying in the C$0.50's earlier this week? It is not too late to get in... here are near term catalysts:
Near term catalysts:
- $12M financing closing next week
- Facility inspection late-May
- Certificate of Occupancy (COO) issued early June
- Production starting immediately following COO
- Conservative revenue estimate at $20M for H2/2017
If you don't heed this advice, you will regret not having purchased LDS within 3 months.
JB
Agreed that they will likely not make it to market as Breathtec, but as for your second comment regarding this type of technology not being cheap, remember that when it comes to publicly traded companies, it's the shareholder's that vote/decide on what a fair price is.
If a hostile party (or friendly one for that matter) comes along and makes a run at BTH, they can offer shareholders C$0.26/sh for a buyout at this time (100% markup to the 30 day average trading price). If there is a sufficient number of shareholders to vote in favour of that, then that's going to be the price that everyone receives for the takeover.
Don't forget that you have Kal out there (and friends and family) that have millions of shares at C$0.075/sh. So an offer by a buyer to pay them C$0.26/sh today would seem like a pretty nice payout (don't forget warrants get triggered too on a takeover).
Always remember:
1) The best defense to a takeover is a high share price
2) The best way to maximize shareholder value in a buyout situation is to start with a high share price
Given the above and were we sit now, we have some work to do...
JB